Daratumumab Market Promising Growth and by Platform Type, Technology and End User Industry Statistics, Scope, Demand by 2034
Daratumumab Market Overview A monoclonal antibody called daratumumab that targets CD38 has become a transformational treatment for a variety of hematologic malignancies, most notably multiple myeloma (MM). The treatment of relapsed/refractory MM and newly diagnosed patients who are not eligible for transplant has been revolutionized by its exceptional efficacy, both when used alone and in...
0 Reacties 0 aandelen 703 Views 0 voorbeeld
Sponsor